These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 35077391)

  • 21. Development and validation of a novel glycolysis-related risk signature for predicting survival in pancreatic adenocarcinoma.
    Li A; Hou S; Chen J; Jiang Y
    Clin Chim Acta; 2021 Jul; 518():156-161. PubMed ID: 33775699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and clinical validation of a necroptosis-related gene signature for prediction of prognosis and tumor immunity in lung adenocarcinoma.
    Lei K; Tan B; Liang R; Lyu Y; Wang K; Wang W; Wang K; Hu X; Wu D; Lin H; Wang M
    Am J Cancer Res; 2022; 12(11):5160-5182. PubMed ID: 36504901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pancreatic adenocarcinoma associated immune-gene signature as a novo risk factor for clinical prognosis prediction in hepatocellular carcinoma.
    Dai L; Mugaanyi J; Cai X; Lu C; Lu C
    Sci Rep; 2022 Jul; 12(1):11944. PubMed ID: 35831362
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identify potential prognostic indicators and tumor-infiltrating immune cells in pancreatic adenocarcinoma.
    Shi T; Gao G
    Biosci Rep; 2022 Feb; 42(2):. PubMed ID: 35083488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of a Necroptosis-Related Prognostic Signature and Associated Regulatory Axis in Liver Hepatocellular Carcinoma.
    He A; Huang Z; Wang J; Lu H; Zhang R; Wu L; Feng Q
    Dis Markers; 2022; 2022():3968303. PubMed ID: 35855852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unraveling the role of Major Vault Protein as a novel immune-related biomarker that promotes the proliferation and migration in pancreatic adenocarcinoma.
    Wu X; Hao L; Lin J; Guo X; Luo Y; Li C
    Front Immunol; 2024; 15():1399222. PubMed ID: 39026679
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification and Validation of Prognostic Model for Pancreatic Ductal Adenocarcinoma Based on Necroptosis-Related Genes.
    Xie H; Xu J; Xie Z; Xie N; Lu J; Yu L; Li B; Cheng L
    Front Genet; 2022; 13():919638. PubMed ID: 35783277
    [No Abstract]   [Full Text] [Related]  

  • 28. The role of m6A-related genes in the prognosis and immune microenvironment of pancreatic adenocarcinoma.
    Tang R; Zhang Y; Liang C; Xu J; Meng Q; Hua J; Liu J; Zhang B; Yu X; Shi S
    PeerJ; 2020; 8():e9602. PubMed ID: 33062408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exploring the significance of novel immune-related gene signatures in the prognosis and immune features of pancreatic adenocarcinoma.
    Chen B; Hu C; Jiang L; Xiang Z; Zuo Z; Lin Y; Liu C
    Int Immunopharmacol; 2021 Mar; 92():107359. PubMed ID: 33465729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A prognostic biomarker of disulfidptosis constructed by machine learning framework model as potential reporters of pancreatic adenocarcinoma.
    Zhang W; Zhao Q; Zhang H; Zhang J; Zhao F; Niu R; Hu X; Wang L; Liu P
    Cell Signal; 2024 Nov; 123():111371. PubMed ID: 39209222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Machine Learning Developed a MYC Expression Feature-Based Signature for Predicting Prognosis and Chemoresistance in Pancreatic Adenocarcinoma.
    Dong B; Zhang Y; Gao H; Liu J; Li J
    Biochem Genet; 2024 Oct; 62(5):4191-4214. PubMed ID: 38245886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of an autophagy-related gene signature for predicting prognosis and immune activity in pancreatic adenocarcinoma.
    Deng J; Zhang Q; Lv L; Ma P; Zhang Y; Zhao N; Zhang Y
    Sci Rep; 2022 Apr; 12(1):7006. PubMed ID: 35488119
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of a necroptosis-related gene signature and the immune landscape in ovarian cancer.
    Nie S; Ni N; Chen N; Gong M; Feng E; Liu J; Liu Q
    J Ovarian Res; 2023 Apr; 16(1):82. PubMed ID: 37095524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of necroptosis-associated miRNA signature for predicting prognosis and immune landscape in stomach adenocarcinoma.
    Zhang S; Liu S; Yue C; Liu Y; Zheng G; Zhang Y
    Exp Cell Res; 2024 Mar; 436(1):113948. PubMed ID: 38307189
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Construction of a novel signature and prediction of the immune landscape in gastric cancer based on necroptosis-related genes.
    Li Z; Yang W; Liu D; Ye W; Du G; Li X
    Sci Rep; 2022 Aug; 12(1):13290. PubMed ID: 35918354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined bulk RNA-seq and single-cell RNA-seq identifies a necroptosis-related prognostic signature associated with inhibitory immune microenvironment in glioma.
    Wan S; Moure UAE; Liu R; Liu C; Wang K; Deng L; Liang P; Cui H
    Front Immunol; 2022; 13():1013094. PubMed ID: 36466844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of a Prognostic Model Based on Pyroptosis-Related Genes in Pancreatic Adenocarcinoma.
    Su K; Peng Y; Yu H
    Dis Markers; 2022; 2022():9141117. PubMed ID: 35677632
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integrated analysis of necroptosis-related genes for evaluating immune infiltration and colon cancer prognosis.
    Yang W; Lu S; Peng L; Zhang Z; Zhang Y; Guo D; Ma F; Hua Y; Chen X
    Front Immunol; 2022; 13():1085038. PubMed ID: 36618366
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AMP‑activated protein kinase family member 5 is an independent prognostic indicator of pancreatic adenocarcinoma: A study based on The Cancer Genome Atlas.
    Xu H; Mao J; Yang X; Chen F; Song Z; Fei J; Chen W; Zhong Z; Wang X
    Mol Med Rep; 2020 Nov; 22(5):4329-4339. PubMed ID: 33000197
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PLAGL1 is associated with prognosis and cell proliferation in pancreatic adenocarcinoma.
    Liang X; Fu Z; Tang L; Zheng M; Chen D; Liu A; Shi L; Yang L; Shao C; Dong X
    BMC Gastroenterol; 2023 Jan; 23(1):2. PubMed ID: 36600208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.